Draft resolutions of
Draft resolutions of the Annual General Meeting of APB APRANGA shareholders to be held on April 28th, 2022
05 avr. 2022 12h05 HE | Apranga
Draft agenda and draft resolutions for the Annual General Meeting of APB APRANGA (hereinafter “Company”) shareholders to be held on April 28th, 2022 proposed by the Board of the Company: ...
APB „APRANGA“ eilini
APB „APRANGA“ eilinio visuotinio akcininkų susirinkimo šaukiamo 2022 m. balandžio 28 d. sprendimų projektai
05 avr. 2022 12h05 HE | APB "Apranga"
APB „APRANGA“ (toliau - Bendrovė) eilinio visuotinio akcininkų susirinkimo, įvyksiančio 2022 m. balandžio 28 d., darbotvarkė ir sprendimų projektai, kuriuos pasiūlė Bendrovės valdyba: ...
Notice of the Annual
Notice of the Annual General Meeting of APB “APRANGA” shareholders
05 avr. 2022 11h44 HE | Apranga
By the initiative and the decision of the Board of APB “APRANGA” the annual general meeting (hereinafter referred to as the Meeting) of APB “APRANGA” (legal entity code 121933274, registered at...
Pranešimas apie APB
Pranešimas apie APB „APRANGA“ šaukiamą eilinį visuotinį akcininkų susirinkimą
05 avr. 2022 11h44 HE | APB "Apranga"
APB „APRANGA“ valdybos iniciatyva ir sprendimu 2022 m. balandžio 28 d. 11 val. šaukiamas APB „APRANGA“ (juridinio asmens kodas 121933274, buveinės adresas: Ukmergės g. 362, Vilnius, toliau –...
Neurones: 7.4% net p
Neurones: 7.4% net profit in 2021
09 mars 2022 11h40 HE | NEURONES
PRESS INFORMATIONHeading: 2021 annual results        Nanterre, March 9, 2022 (after trading) 7.4% net profit in 2021 Accounts as at December 31 (audited and in...
NEURONES : 7,4% de r
NEURONES : 7,4% de résultat net en 2021
09 mars 2022 11h40 HE | NEURONES
INFORMATION PRESSERubrique : Résultats annuels 2021        Nanterre, le 9 mars 2022 (après Bourse) 7,4% de résultat net en 2021 Comptes au 31 décembre (audités et en M€)201920202021Chiffre...
Neurones: Growth up
Neurones: Growth up 10.6% in 2021
09 févr. 2022 11h40 HE | NEURONES
PRESS INFORMATIONHeading: 2021 annual revenues        Nanterre, 9 February 2022 (after trading) Growth up 10.6% in 2021 (unaudited, in € millions)20202021growth of which...
NEURONES : + 10,6% d
NEURONES : + 10,6% de croissance en 2021
09 févr. 2022 11h40 HE | NEURONES
INFORMATION PRESSERubrique : C.A. annuel 2021        Nanterre, le 9 février 2022 (après Bourse) + 10,6% de croissance en 2021 (non audités, en millions d’euros)20202021Croissancedont organiqueChiffre...
Realtors® to “Rise a
Realtors® to “Rise and Shine” During Annual Conference & Expo in San Diego
03 nov. 2021 10h00 HE | National Association of Realtors®
Washington, D.C., Nov. 03, 2021 (GLOBE NEWSWIRE) -- One week from today, Realtors® from across the country and around the world will gather in San Diego to experience the premier global event for...
Beroni Logo @ Dec 2019.png
Beroni Group Received Approval for 43.5% R&D Rebate from Australian Government for the Novel, Potential Anti-Cancer Drug PENAO
09 sept. 2021 08h30 HE | Beroni Group Limited
NEW YORK and SYDNEY, Australia, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni”), an Australia-based biopharmaceutical enterprise, today announced that PENAO Pty...